Feb 10 (Reuters)-
Garna Biosciences Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2016 Dec 31, 2015 Dec 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 811 mln 1.57 1.44
(-48.3 pct) (+156.5 pct) (+77.4 pct)
Operating loss 423 mln 472 mln 39 mln
Recurring loss 440 mln 492 mln 35 mln
Net
Net loss 289 mln 456 mln 6 mln
EPS loss 31.64 yen 52.61 yen 0.71 yen
EPS Diluted 50.05 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Garna Biosciences Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T
((Tokyo Headline News Desk +813 6441 1812))